Ecolab has reached an agreement to acquire AkzoNobel’s Purate business, which specialises in global antimicrobial water treatment technology. The transaction is awaiting customary regulatory clearances and other standard closing conditions. The Purate business provides patented, proprietary chlorine dioxide programmes for use in a wide array of water treatment applications.
“Chlorine dioxide is recognised as an excellent antimicrobial agent to control biologic growth primarily in cooling towers and a wide variety of other industrial water treatment applications,” says Timothy Mulhere, Ecolab executive vice president and president, Global Water and Process Services.
“Purate’s patented technologies complement our offerings globally, including our 3D Trasar technology programmes, which help address our customers’ needs for clean water within industrial manufacturing and lower total cost of operations.” Purate 2012 revenue was approximately $23 million.
